Parataxis Holdings, an affiliate of digital asset-focused funding firm Parataxis Capital Administration, is ready to launch a Bitcoin-native treasury platform within the South Korean public market.
The agency announced on Friday it had entered a definitive settlement to take a position 25 billion South Korean received ($18.5 million) into Bridge Biotherapeutics, a publicly traded biotech firm.
Following the acquisition, Parataxis will take a controlling curiosity within the agency, which can be renamed Parataxis Korea and repurposed as a treasury car for institutional Bitcoin (BTC) publicity.
“Impressed by the rising curiosity in BTC treasury methods seen in corporations like Technique within the US and Metaplanet in Japan, we imagine institutional curiosity on this house is growing globally,” mentioned Andrew Kim, Accomplice at Parataxis Capital. “We see South Korea as an essential market within the evolution of BTC adoption.”
Kim added that the agency’s intent is to assist institutional entry to Bitcoin whereas emphasizing sound company governance and disciplined capital administration.
Presently, Bitcoin exchange-traded funds (ETFs) and institutional crypto investments are banned in South Korea.
Nevertheless, the nation’s Monetary Providers Fee (SFC) has allowed 3,500 corporations and professional buyers to open “real-name” accounts within the first half of 2025 as a part of a pilot program aiming to progressively allow institutional digital asset investments.
Associated: ‘Apple should buy Bitcoin,’ Saylor says, as share buyback disappoints
Parataxis’ new platform was introduced over per week after the New York-headquartered agency introduced plans to go public by means of a $200 million special acquisition firm, Cointelegraph reported on June 10.
The Parataxis announcement comes amid a wave of company Bitcoin adoption. Greater than 237 public corporations now maintain Bitcoin on their stability sheets, up from 124 firms just weeks earlier, representing roughly 3.96% of the entire BTC provide, according to BitcoinTreasuries.NET.
Associated: Nasdaq-listed Mercurity Fintech to raise $800M for Bitcoin treasury
Inventory rallies comply with treasury bulletins
Bridge Biotherapeutics’ inventory rose greater than 20% on the every day chart following information of the acquisition, according to TradingView knowledge. Nevertheless, the biotech agency’s inventory stays down 74% year-to-date and over 90% from its five-year excessive.
Based in 2015 and listed on the Korean Securities Sellers Automated Quotations in 2019, Bridge Biotherapeutics develops therapeutics for the remedy of ulcerative colitis, fibrotic illnesses and most cancers.
Earlier right this moment, London-based synthetic intelligence options agency Pri0r1ty Intelligence Group announced plans to undertake Bitcoin as a reserve asset and fee resolution with out disclosing a direct Bitcoin funding.
Following the announcement, the agency’s inventory worth rose over 84% on the every day chart, reversing its one-year downtrend of 32%, Google Finance knowledge exhibits.
Not all corporations are benefiting equally. GameStop shares fell more than 22% after the online game retailer elevated its convertible be aware providing to $2.25 billion, which some analysts interpreted as a sign of additional crypto-related investments.
Journal: Arthur Hayes $1M Bitcoin tip, altcoins ‘powerful rally’ looms: Hodler’s Digest, May 11 – 17
